Patents Assigned to Technion Research & Development
  • Publication number: 20190316082
    Abstract: Well-defined, xeno-free culture media which comprise a TGF-beta isoform or the chimera formed between IL6 and the soluble IL6 receptor (IL6RIL6), which are capable of maintaining stem cells, and particularly, human embryonic stem cells, in an undifferentiated state are provided. Also provided are cell cultures comprising the culture media and the stem cells and methods of expanding and deriving embryonic stem cells in such well-defined, xeno-free culture media. In addition, the present invention provides methods of differentiating ESCs or EBs formed therefrom for the generation of lineage specific cells.
    Type: Application
    Filed: June 27, 2019
    Publication date: October 17, 2019
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Michal AMIT, Joseph ITSKOVITZ-ELDOR
  • Patent number: 10448217
    Abstract: A channel distribution system has a channel carrying content, and an interactive receiver which receives content and provides to a user. The interactive receiver has an interface to allow the user to interact with the content. The channel also includes a broadcast label superimposed on the content which invites the user to interact with the content. The label includes an interactive link with a digital instruction containing handling information for the interactive receiver device. The handling information tells the interactive receiver how to handle a user interaction coinciding with the label.
    Type: Grant
    Filed: September 15, 2014
    Date of Patent: October 15, 2019
    Assignee: Technion Research & Development Foundation Limited
    Inventor: Oded Shmueli
  • Publication number: 20190309368
    Abstract: Provided are methods and kits for determining predisposition of a subject to develop a kidney disease, by identifying in a sample of the subject at least one APOL1 polypeptide variant which is characterized by a higher trypanolytic activity on Trypanosoma brucei rhodesiense as compared to the trypanolytic activity of wild type APOL1 polypeptide as set forth in SEQ ID NO:1 on the Trypanosoma brucei rhodesiense under identical assay conditions; or at least one APOL1 nucleotide mutation in the APLO1 genomic sequence set forth in SEQ ID NO:3, wherein the at least one nucleotide mutation or polypeptide variant being in linkage disequlibrium (LD) with the S342G mutation in the APOL1 polypeptide set forth in SEQ ID NO:1, wherein presence of the APOL1 polypeptide variant indicates increased predisposition of the subject to develop the kidney disease.
    Type: Application
    Filed: June 24, 2019
    Publication date: October 10, 2019
    Applicants: Technion Research & Development Foundation Limited, Ramot at Tel-Aviv University Ltd., Rambam Med-Tech Ltd.
    Inventors: Karl SKORECKI, Shay TZUR, Saharon ROSSET, Walter Gabriel WASSER, Doron M. BEHAR, Revital SHEMER
  • Patent number: 10434068
    Abstract: A microparticle for cell encapsulation is provided, having a core which comprises continuous fibers of decellularized extracellular matrix (ECM) and, optionally, an outer layer. Also provided are methods of encapsulating cells in the microparticle, pharmaceutical compositions comprising the microparticle, and methods of treating disease in animals employing the microparticles of the invention, for example, treating Diabetes.
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: October 8, 2019
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Marcelle Machluf, Deborah Chaimov
  • Patent number: 10400273
    Abstract: Provided are methods and systems for parallel analysis of a single cell's nucleic acid.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: September 3, 2019
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Itai Yanai, Uri Sivan, Elad Brod, Tamar Hashimshony, Anatoly Senderovich
  • Patent number: 10398718
    Abstract: A new class of pseudo-trisaccharide aminoglycosides having an alkyl group at the 5? position, exhibiting efficient stop codon mutation readthrough activity, low cytotoxicity and high selectivity towards eukaryotic translation systems are provided. Also provided are pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders, as well as processes of preparing these aminoglycosides. The disclosed aminoglycosides can be represented by the general formula I: or a pharmaceutically acceptable salt thereof, wherein R1 is selected from the group consisting of alkyl, cycloalkyl and aryl; and all other variables and features are as described in the specification.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: September 3, 2019
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Timor Baasov, Dana Atia-Glikin, Jeyakumar Kandasamy, Valery Belakhov
  • Patent number: 10387208
    Abstract: A method comprising, in a cloud computing system: receiving a new job at the cloud computing system; sampling VMs (Virtual Machines) of the cloud computing system for the load currently handled by each of the VMs; if the load currently handled by the VMs is within operational bounds, sending the new job to one of the VMs which currently handles the highest load compared to other ones of the VMs; and if the load currently handled by the VMs is beyond operational bounds, sending the new job to one of the VMs which currently handles the lowest load compared to other ones of the VMs.
    Type: Grant
    Filed: July 14, 2015
    Date of Patent: August 20, 2019
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Amir Nahir, Ariel Orda, Dan Raz
  • Patent number: 10385312
    Abstract: Well-defined, xeno-free culture media which comprise a TGF-beta isoform or the chimera formed between IL6 and the soluble IL6 receptor (IL6RIL6), which are capable of maintaining stem cells, and particularly, human embryonic stem cells, in an undifferentiated state are provided. Also provided are cell cultures comprising the culture media and the stem cells and methods of expanding and deriving embryonic stem cells in such well-defined, xeno-free culture media. In addition, the present invention provides methods of differentiating ESCs or EBs formed therefrom for the generation of lineage specific cells.
    Type: Grant
    Filed: July 14, 2016
    Date of Patent: August 20, 2019
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Michal Amit, Joseph Itskovitz-Eldor
  • Patent number: 10379751
    Abstract: A method for reducing disk read rate by managing dataset mapping of virtual machine (VM) guest memory, comprising: monitoring a plurality of disk read write operations of a VM guest; updating a dataset mapping between disk blocks allocated to the VM guest and corresponding physical addresses of memory pages of the VM guest containing replica of data stored in the disk blocks, based on the plurality of disk read write operations; when identifying writing to one of the memory pages, removing a mapping of corresponding disk block and corresponding physical address of memory page; when reclaiming a mapped memory page of the VM guest by a host of the VM guest, discarding data contained in the memory page; and when the data is requested by the VM guest after it was reclaimed by said host, retrieving the data from corresponding disk block according to the mapping.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: August 13, 2019
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Assaf Schuster, Nadav Amit, Dan Tsafrir
  • Patent number: 10370630
    Abstract: According to an aspect of some embodiments, an apparatus for isolation and cytometric analysis of cells from a liquid medium is provided. The apparatus comprises a cell reservoir, for receiving a liquid medium containing a suspension of cells. The apparatus further comprises a cell cage array between the cell reservoir and an enclosed reservoir, each cell cage comprising a large opening adjacent to the first cell reservoir, a cell cage, and one or more small opening adjacent to the enclosed reservoir. A connected liquid medium pump may move the suspended cells into cell cages by flowing the liquid medium from the cell reservoir to the enclosed reservoir. The apparatus further comprises a mechanical element which when actuated, pushes the cell cage array against a gel layer, forming a contiguous barrier to isolate each cell in a cell cage, and allowing cytometric analysis of isolated cells.
    Type: Grant
    Filed: February 10, 2015
    Date of Patent: August 6, 2019
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Uri Sivan, Elad Brod
  • Patent number: 10365298
    Abstract: A detection arrangement and method for directing the sensitivity of an optical knife-edge detection system to its optimal operating point. This is referred to as an increase in the detection dynamic range of the system with advantageous applications for detecting motion of a surface such as for Atomic Force Microscopy as well as detecting acoustic vibrations on unstable surfaces. A pair of parallel reflecting surfaces, such as an optical slab waveguide, serve to reflect the sensing beam back onto the knife-edge detector once it is shifted off its sensing range. Allowing multiple reflections, the sensing beam is maintained on the knife-edge detector even at large angular offsets from the optimal operating point of the basic knife-edge detector. Use of a modified arrangement, with two knife-edge detectors at quadrature ensures near-optimal sensitivity at a detection dynamic range up to forty-fold larger than that of the basic knife-edge system.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: July 30, 2019
    Assignee: Technion Research & Development Foundation Limited
    Inventor: Abraham Aharoni
  • Publication number: 20190224226
    Abstract: A new class of pseudo-trisaccharide aminoglycosides having an alkyl group at the 5? position, exhibiting efficient stop codon mutation readthrough activity, low cytotoxicity and high selectivity towards eukaryotic translation systems are provided. Also provided are pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders, as well as processes of preparing these aminoglycosides. The disclosed aminoglycosides can be represented by the general formula I: or a pharmaceutically acceptable salt thereof, wherein R1 is selected from the group consisting of alkyl, cycloalkyl and aryl; and all other variables and features are as described in the specification.
    Type: Application
    Filed: March 7, 2018
    Publication date: July 25, 2019
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Timor BAASOV, Dana ATIA-GLIKIN, Jeyakumar KANDASAMY, Valery BELAKHOV
  • Publication number: 20190227293
    Abstract: A system comprising: a dielectric configured to: a) create a bi-periodic interference pattern of two standing sinusoidal waves on illumination by two pairs of counter-propagating light beams at different incident angles, wherein the incident angles are selected in accordance with the index of refraction of the dielectric to i) to determine the spatial frequency of each counter-propagating light wave pair, and ii) cause total internal reflection, and b) generate, from the bi-periodic interference pattern, an evanescent bi-periodic standing sinusoidal wave; a light source configured to illuminate the dielectric with the two pairs of counter-propagating sinusoidal light waves at the selected incident angles and thereby illuminate a fluorescing object positioned at the surface of the dielectric with the generated bi-periodic evanescent standing sinusoidal wave; and one or more delay lines configured to independently modify the initial phase of each counter-propagating light wave pair.
    Type: Application
    Filed: July 18, 2017
    Publication date: July 25, 2019
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Guy BARTAL, Bergin GJONAJ, Yacob Yochai BLAU, Doron SHTERMAN
  • Publication number: 20190224125
    Abstract: Compositions comprising liposomes composed of whole cell membrane fraction are provided. The liposomes may be attached to, or encapsulate a pharmaceutical agent. Also provided are methods of generating and using these liposomes.
    Type: Application
    Filed: April 2, 2019
    Publication date: July 25, 2019
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Marcelle MACHLUF, Tomer BRONSHTEIN
  • Publication number: 20190217309
    Abstract: A method for dielectrophoresis includes applying an electric field across a micro-fluidic chamber with an alternating current (AC), trapping the target particles on the at least one carrier particle, transporting the target particles from a first location in the chamber to a second location in the chamber distanced from the first location with the at least one carrier particle and dynamically controlling the trapping and the transporting based on remotely applying forces on the at least one carrier particle. The trapping is based on localized gradients of the electric field induced by the carrier particle. The applied electric field is uniform absent a carrier particle present in the micro-fluidic chamber. The micro-fluidic chamber contains an electrolyte-solution with suspended target particles and at least one carrier particle freely floating on or in the electrolyte-solution.
    Type: Application
    Filed: June 2, 2017
    Publication date: July 18, 2019
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Gilad YOSSIFON, Alicia BOYMELGREEN
  • Patent number: 10351911
    Abstract: Provided are methods and kits for determining predisposition of a subject to develop a kidney disease, by identifying in a sample of the subject at least one APOL1 polypeptide variant which is characterized by a higher trypanolytic activity on Trypanosoma brucei rhodesiense as compared to the trypanolytic activity of wild type APOL1 polypeptide as set forth in SEQ ID NO:1 on the Trypanosoma brucei rhodesiense under identical assay conditions; or at least one APOL1 nucleotide mutation in the APLO1 genomic sequence set forth in SEQ ID NO:3, wherein the at least one nucleotide mutation or polypeptide variant being in linkage disequlibrium (LD) with the S342G mutation in the APOL1 polypeptide set forth in SEQ ID NO:1, wherein presence of the APOL1 polypeptide variant indicates increased predisposition of the subject to develop the kidney disease.
    Type: Grant
    Filed: April 24, 2016
    Date of Patent: July 16, 2019
    Assignees: Technion Research & Development Foundation Limited, Ramot at Tel-Aviv University Ltd., Walter Gabriel WASSER, Rambam Med-Tech Ltd.
    Inventors: Karl Skorecki, Shay Tzur, Saharon Rosset, Walter Gabriel Wasser, Doron M. Behar, Revital Shemer
  • Patent number: 10356317
    Abstract: A system for wide-scale light field imaging comprising: a network of multiple terrestrial cameras positioned at multiple known locations, where each of the cameras comprises a wide-angle lens directed towards the sky and configured to capture one or more images of the sky, and a processor configured to operate a wired and/or wireless communications infrastructure for transmitting the captured images; and a server configured to receive the wirelessly transmitted images and jointly process the received images, thereby producing a wide-scale light field image of the sky.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: July 16, 2019
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Yoav Y. Schechner, Dmitri Veikherman, Amit Aides
  • Publication number: 20190210288
    Abstract: There is provided a method of representing a three dimensional (3D) object using univariate curves, comprising: receiving an initial definition of a 3D object representation, calculate a covering set of univariate curves, the covering set comprising at least one non-planar univariate curve, wherein the covering set of univariate curves represent the volume of the 3D object within a tolerance requirement, and generating a representation of the 3D object based on the set of univariate curves, wherein the set of univariate curves represent the volume of the 3D object.
    Type: Application
    Filed: August 10, 2017
    Publication date: July 11, 2019
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Gershon ELBER, Ben EZAIR
  • Publication number: 20190194083
    Abstract: A polyHIPE-based substance-releasing system capable of releasably encapsulating a highly concentrated solution and/or a room temperature solid while minimizing or avoiding burst release from the closed-cell microstructure of an elastic polyHIPE.
    Type: Application
    Filed: August 16, 2017
    Publication date: June 27, 2019
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Michael S. SILVERSTEIN, Katya KAPILOV-BUCHMAN, Reinhard EFFENBERGGER, Dorit CANFI
  • Publication number: 20190163672
    Abstract: A method of applying proof of lottery to select block forgers in a blockchain, comprising performing the following at a certain one of a plurality of computing nodes connected to a blockchain network: (1) transmitting one or more of a plurality of participation transactions submitted by at least some of the plurality of computing nodes for participating in selection process conducted to select forgers from the plurality of computing nodes to forge blocks to be added to the blockchain; (2) determining a respective forger, during each selection process, by applying a selection function to an outcome of a hash function and a plurality of participation transactions extracted from a first subset of blocks preceding the respective block, the hash function is applied to a second subset of blocks preceding the respective block; and (3) forging the respective block in case the certain computing node is selected as the respective forger.
    Type: Application
    Filed: November 29, 2018
    Publication date: May 30, 2019
    Applicant: Technion Research & Development Foundation Limited
    Inventor: Oded SHMUELI